Saudi Arabia Pharmaceuticals Market Size, Share, Growth, and Forecast, 2026 to 2033
The Saudi Arabia pharmaceuticals market is estimated to grow from US$ 12.1 billion in 2026 to US$ 17.1 billion by 2033. The market is projected to record a CAGR of 5.0% during the forecast period from 2026 to 2033 driven by rising chronic disease prevalence, growing healthcare expenditure, and strong government support under Vision 2030.
Increasing demand for biologics, specialty drugs, and localized manufacturing boosts growth. Expanding hospital infrastructure and insurance coverage further accelerate market development across prescription and specialty therapeutic segments nationwide.